Dr Bernard Vallat Director General, OIE Global control and - PowerPoint PPT Presentation

Dr Bukar Tijani Assistant Director General, FAO Dr Bernard Vallat Director General, OIE Global control and eradication of peste des petits ruminants Investing in veterinary systems, food security and poverty alleviation

Global control and eradication of peste des petits ruminants High Stakes Role of the FAO Global PPR Control and Eradication Strategy Role of the OIE Conclusions

High Stakes Dr Bukar Tijani , ADG FAO Livestock and Nutrition Some 805 million people in the world suffer from chronic malnutrition. Animal source food provides a critical supplement and diversity to staple plant-based diets, and are particularly appropriate for combating > undernutrition > malnutrition > range of nutritional deficiencies. Milk and meat from small ruminants are > energy-dense > good sources of protein > vitamins > micronutrients.

Livestock and Nutrition Animal source foods can enhance quality in diets (especially children, elderly, and expectant pregnant and lactating women) Consumption of milk or meat is often low in undernourished populations; under these critical circumstances even moderate increases in consumption provide valuable nutritional benefits. Diseases, like PPR, deprive populations from valuable foods Diseases impact production efficiencies

 Small ruminants : heads per km 2 Rural poverty and small ruminant density

 Small ruminants : heads per km 2 Rural poverty and small ruminant density Rural poor  Less than USD 2/Day number/km 2

Livestock and Poverty Reduction Halving extreme poverty by the end of 2015 has been met (MDGs) Yet, the world still counts more than one billion people that live in extreme poverty Livestock provide ~ 26 percent of human global protein consumption and 13 percent of total calories Livestock sector employs 1.3 billion people Livelihood to 1 billion poor, 70 percent of whom are women

Livestock and Poverty Reduction By 2050 population growth - from 7.2 billion to 9.6 billion Growing incomes, urbanization, increased demand for animal-source foods is projected to increase Compared to consumption levels in 2010, by 2050 demand for: pork and eggs will increase by 65-70 percent; o for beef, dairy products o and mutton by 80-100 percent; o and demand for poultry meat is projected to increase by 170 percent. o

Why PPR? Large share of rural households keep sheep and goats Millions ions of poor will benefi efit t from policies and investments that foster inclusive development of the small ruminant sub sector. The control of PPR is among the most promising investments. Large productivity gap in the small ruminant sector due to PPR o Pre-weaning mortality o Reduced productivity o Households lose their assets because of disease o Controlling diseases, such as PPR will positively impact the livelihood of millions of households .

Why PPR? Demand for small ruminant products is growing fast (FAO projections) Between 2000 and 2030, mutton consumption will increase rease by over 7 million MT o per year worldwide, with fa fast st growth h in developing countries. Between 2000 and 2030, mutton consumption will increa ease se by 1.7 million MT o per year in South Asia; Annual increas ase in mutton consumption in sub-Saharan will be about 1.8 milllion o MT. This increase in demand will generat ate e new opportu tuni niti ties es for small ruminant o producers. Eliminating losses due to diseases will increase ase their compe mpeti titi tiven enes ess. o

Role of FAO Improve nutrition, health, and protect consumers Reduce poverty and hunger; protect livelihoods Sustainable development o Promote economic growth o Self-determination o Diversity o Gender equality

Role of FAO Capacity Building o Local, national, regional o Promoting international standards Policy development and guidance Neutral forum 194 membership; 1000’s reference centres ; 100’s partners o UN family – WHO, IAEA, UNICEF, UNHCR, ILO, UNDP, UNEP, WTO o NGO’s and CSO’s Governing Bodies on Food Security, Fisheries, Forestry, and Agriculture/Livestock

S/SE Asia-2012 N D M H F G C K J T B P A E I R S L O LMT Category 89 56 56 56 56 67 33 89 33 56 33 22 44 33 67 22 11 33 33 Geographic location 89 78 67 67 78 78 67 67 33 44 67 56 50 33 33 11 11 22 0 Laboratory Budget 89 78 56 89 67 67 78 89 78 67 44 56 78 33 89 56 22 33 56 Basic supply 100 100 100 100 100 100 100 67 100 67 100 100 100 100 100 67 67 67 33 Organization 63 50 54 83 50 58 58 63 71 67 50 42 54 42 50 29 24 38 33 Infrastructure 61 89 72 67 50 56 61 56 42 61 61 39 56 44 28 56 40 40 33 Equipment 75 83 63 75 75 71 75 79 89 71 71 58 75 63 62 75 43 38 25 Reagent supply 83 100 79 71 75 63 67 50 83 62 75 63 71 71 71 54 58 54 21 Staff skills + availability 72 67 72 50 72 72 56 72 n/d 47 61 72 72 72 17 56 50 28 17 Sample accession 67 59 63 56 63 48 48 56 52 50 67 48 58 52 59 48 30 30 30 Available technology 67 67 62 38 43 43 38 33 38 29 29 62 33 38 33 0 10 5 29 Training , including IATA 83 88 63 63 75 100 79 63 58 54 75 63 67 67 67 21 33 0 17 Quality Assurance 80 39 56 56 33 33 44 50 47 87 33 33 22 39 33 20 56 27 22 Biosafety/Biosecurity 100 44 67 33 44 22 22 22 44 33 33 56 33 33 33 0 22 0 0 Staff Security/Health 83 58 67 83 67 58 75 75 67 92 50 33 58 58 83 50 58 58 17 Communication means 89 33 78 n/d 78 89 83 33 n/d 78 56 78 11 44 n/d 67 56 33 0 National lab networking 87 60 87 53 73 53 40 47 67 53 60 87 60 33 47 40 40 33 47 Laboratory collaboration 83 50 58 92 75 58 67 75 33 42 50 58 17 67 17 0 17 0 25 Use of databases/platforms 2014 77 68 66 64 63 61 59 59 58 58 57 55 54 52 50 38 36 29 25 Grand Total 2011 (% (%) LMT Category N C D A M F H K T T G B J E P R S I O L 89 67 67 78 56 78 56 78 100 100 78 67 33 56 22 44 44 67 56 33 Geographic location 89 89 100 67 67 78 67 67 89 89 78 89 56 33 56 56 56 33 22 11 Laboratory Budget 89 89 89 78 78 78 89 89 89 89 78 44 100 56 56 78 89 89 100 33 Basic supply 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 67 Organization 63 67 54 67 54 58 71 63 46 46 58 58 71 46 38 38 38 50 42 33 Infrastructure 94 78 83 72 72 56 61 72 50 50 67 67 42 50 39 53 44 28 33 39 Equipment 83 100 88 88 67 79 75 83 79 79 75 75 94 63 58 58 50 54 38 33 Reagent supply 83 100 100 88 83 79 71 71 75 75 75 71 81 79 63 46 50 71 33 33 Staff skills + availability 72 83 83 78 72 61 67 83 39 39 83 72 40 78 72 63 72 17 50 28 Sample accession 70 59 63 56 63 67 52 63 58 58 52 74 58 56 48 41 31 59 30 26 Available technology 71 71 67 57 62 62 52 52 43 43 43 43 57 57 67 10 10 33 52 5 Training , including IATA 83 88 96 83 79 83 96 67 50 50 100 88 71 83 71 46 42 67 63 8 Quality Assurance 89 72 61 67 72 61 67 61 83 83 56 50 73 61 50 44 67 33 50 28 Biosafety/Biosecurity 100 56 67 67 89 56 78 44 100 100 22 56 44 33 56 67 44 33 33 0 Staff Security/Health 83 83 100 67 67 67 83 83 83 83 67 75 67 67 50 67 58 83 50 58 Communication means 89 78 67 22 78 78 n/d 44 78 78 89 33 44 67 78 67 89 n/d 0 33 National lab networking 87 47 60 67 87 80 53 67 80 80 60 60 67 47 87 53 40 47 60 33 Laboratory collaboration 83 83 67 75 58 75 92 75 92 92 58 58 67 75 58 58 67 17 25 0 Use of databases/platforms Grand Total 2011 (% (%) 81 78 77 71 71 70 70 69 68 68 67 66 65 61 58 49 49 48 44 26

Regional Laboratory networking in Sub-Saharan Africa RESOLAB-WA EARLN Regional Support Laboratories RESOLAB-CA LABNET Similar in Eastern/SE Asia and South Asia … needs for Central Asia and Middle East

Dr Bernard Vallat Director General-OIE Global Control and Eradication Strategy Role of the OIE

Global Control and Eradication Strategy - Component 1: Control and eradication of PPR - Component 2: Strengthening Veterinary Services - Combining 3: Combining control activities with other diseases 19

The Progressive Step-wise Approach for the prevention and control of PPR Fast-track procedure

Each Stage is described by the following aspects • To gain a better epidemiological understanding of the presence Stage of PPR 1 • To control both PPR clinical disease and infection in a Stage specific area or production 2 system • To achieve the eradication of Stage PPR from the national territory of the country 3 • To build evidence that, after suspension of vaccination, Stage there is no clinical disease 4 and no virus circulation 21

Capacity of OIE official recognition Veterinary Services (chapters 14.7 and 1.6) Considered as Application the ‘Enabling for OIE endorsed PPR Environment’ control programme (chapters 14.7 (compliance with and 1.6) OIE Standards step-wise approach as well) OIE standards on quality of VS Level 3 of OIE PVS Critical Competence 27 33 12 29 CCs CCs CCs CCs 22